General anesthetics have been a mainstay of surgical practice for more than 150 years, but the mechanisms by which they mediate their important clinical actions remain unclear. Ion channels represent important anesthetic targets, and, although GABA A receptors have emerged as major contributors to sedative, immobilizing, and hypnotic effects of intravenous anesthetics, a role for those receptors is less certain in the case of inhalational anesthetics. The neuronal hyperpolarization-activated pacemaker current (I h ) is essential for oscillatory and integrative properties in numerous cell types. Here, we show that clinically relevant concentrations of inhalational anesthetics modulate neuronal I h and the corresponding HCN channels in a subunit-specific and cAMP-dependent manner. Anesthetic inhibition of I h involves a hyperpolarizing shift in voltage dependence of activation and a decrease in maximal current amplitude; these effects can be ascribed to HCN1 and HCN2 subunits, respectively, and both actions are recapitulated in heteromeric HCN1-HCN2 channels. Mutagenesis and simulations suggest that apparently distinct actions of anesthetics on V 1/2 and amplitude represent different manifestations of a single underlying mechanism (i.e., stabilization of channel closed state), with the predominant action determined by basal inhibition imposed by individual subunit C-terminal domains and relieved by cAMP. These data reveal a molecular basis for multiple actions of anesthetics on neuronal HCN channels, highlight the importance of proximal C terminus in modulation of HCN channel gating by diverse agents, and advance neuronal pacemaker channels as potentially relevant targets for clinical actions of inhaled anesthetics.
Introduction
General anesthetics represent some of the most widely used and useful drugs in clinical medicine; despite their prevalent use, however, the fundamental neural mechanisms by which they exert their actions remain uncertain. It is now generally accepted that specific membrane proteins, particularly ion channels, provide the relevant substrate for anesthetic actions (Franks and Lieb, 1994; Krasowski and Harrison, 1999) . The ionotropic GABA A receptor has garnered the most attention in this respect, and this emphasis has received elegant validation at the systems level; mice bearing targeted mutations that selectively eliminate anesthetic sensitivity of GABA A receptors containing ␤2 or ␤3 subunits display either altered sedative (␤2N265S) or anesthetic responses (␤3N265M) to intravenous anesthetic agents (e.g., etomidate or propofol) (Jurd et al., 2003; Reynolds et al., 2003) (for review, see Rudolph and Mohler, 2004) . Interestingly, however, anesthesia induced with inhalational anesthetics (e.g., enflurane) was minimally affected in ␤3N265M mice, although that mutation blocks GABA A receptor modulation by enflurane (Jurd et al., 2003) , suggesting that alternative molecular substrates contribute to actions of inhalation anesthetics (Harrison, 2003; Sonner et al., 2003) .
Additional candidate molecular targets for actions of inhalational anesthetics may be found within various classes of subthreshold ion channels that regulate intrinsic neuronal excitability. For example, discovery of the two-pore-domain potassium ion channel family has provided a molecular basis for early observations that "background" K ϩ currents are activated by inhalational anesthetics (Franks and Lieb, 1988; Patel et al., 1999) . For TASK (TWIK-related acid-sensitive K ϩ channels) and TREK (TWIK-related K ϩ channel) members of this family, channel domains critical for anesthetic actions have been identified (Patel et al., 1999; Talley and Bayliss, 2002) , and, in the case of TREK-1, a knock-out mouse displayed reduced sensitivity to volatile anesthetics (Heurteaux et al., 2004) . Likewise, it is now recognized that the HCN family of ion channels gives rise to the cyclic nucleotide-sensitive, hyperpolarization-activated cationic currents, variously called I h , I f , and I q Santoro and Tibbs, 1999; Kaupp and Seifert, 2001) ; these currents are renowned for providing a cAMP-modulated, subthreshold pacemaker activity in rhythmically oscillating cells of the heart and brain (DiFrancesco, 1993; Pape, 1996; Clapham, 1998; Lüthi and McCormick, 1998) , and, of relevance here, we found that they are strongly modulated by inhalation anesthetics (Sirois et al., 1998 (Sirois et al., , 2002 . Although it has been established that HCN channels represent the molecular basis for native I h , it is not certain which HCN subunits mediate anesthetic actions and/or which domains of the proteins are responsible for channel inhibition.
Here, we recorded from neurons in brain slices and from human embryonic kidney 293 (HEK293) cells transfected with HCN1 and HCN2 subunits to characterize anesthetic effects on native neuronal I h and to determine the molecular basis for inhibition of I h by inhalation anesthetics. Inhibition of neuronal I h resulted from a hyperpolarizing shift in the voltage dependence of current activation and a decrease in maximal current amplitude. These two inhibitory effects were observed at clinically relevant anesthetic concentrations, and each was associated with a distinct HCN subunit. The subunit-specific inhibitory actions reflect differential allosteric modulation of the channels by their respective C termini, and the relative expression of each component of inhibition was modulated in turn by cAMP interactions with those C-terminal regions. Our data indicate, therefore, that characteristics of anesthetic inhibition of I h are determined by both HCN subunit composition and prevailing cAMP levels.
Materials and Methods
Brain slice preparation. Neonatal rats (7-14 d postnatal) were decapitated under ketamine and xylazine anesthesia, and transverse slices (200 m) were prepared from the brainstem and thalamus using a microslicer (DSK 1500E; Dosaka, Kyoto, Japan) in ice-cold substituted Ringer's solution containing the following (in mM): 260 sucrose, 3 KCl, 5 MgCl 2 , 1 CaCl 2 , 1.25 NaH 2 PO 4 , 26 NaHCO 3 , 10 glucose, and 1 kynurenic acid. Slices were incubated for 1 h at 37°C and subsequently at room temperature in normal Ringer's solution containing the following (in mM): 130 NaCl, 3 KCl, 2 MgCl 2 , 2 CaCl 2 , 1.25 NaH 2 PO 4 , 26 NaHCO 3 , and 10 glucose. Both substituted and normal Ringer's solutions were bubbled with 95% O 2 /5% CO 2 . Slices were submerged in a chamber mounted on a fixed-stage microscope (Axioskop FS; Zeiss, Oberkochen, Germany), and neurons were visualized using Nomarski optics and identified by their location in the slice.
HCN channel constructs. We obtained mouse HCN channel constructs from Drs. B. Santoro and S. A. Siegelbaum (Columbia University, New York, NY). Wild-type mHCN1 and mHCN2 were provided in pTracer and subcloned into pcDNA3 using EcoRI and XbaI. To generate a concatemeric HCN1-HCN2 construct, we used overlap extension PCR to produce a PshAI-NheI fragment that spliced the final leucine of HCN1 directly in frame with the initiating methionine of HCN2, with no additional intervening sequence. HCN channel chimeras are exactly as described previously ; they were obtained in pGH19 or pGHE and subcloned into pcDNA3-HE3 for recording in HEK293 cells.
To engineer a pair of chimeras that swapped the core channel domains of transmembrane segments between HCN1 and HCN2, we first used the primers 5Ј-CACCAGTGGGAAGAGATTTTCCACATGACCTATGA-CCT-3Ј and 5Ј-TTGTGGAATGACATGTATTGCTCTACTTGCTTG-TACTTCTC-3Ј to amplify a 431 bp cDNA fragment that included the fifth and sixth transmembrane domains and intervening pore helix of HCN1 or HCN2, respectively. These fragments were then purified and used as primers in a QuickChange PCR to generate HCN1-2(S5-S6) and HCN2-1(S5-S6). We used QuickChange PCR to introduce stop codons immediately after the final transmembrane segment of HCN1(S391stop) or HCN2(S444stop) to make the C-terminal deletion mutants, HCN1⌬Cterm and HCN2⌬Cterm, and we generated an HCN1(V473stop) and HCN2(V526stop) to delete the cyclic nucleotide binding domain (CNBD) and extreme C terminus of the two HCN subunits (HCN1⌬CNBD and HCN2⌬CNBD) . The sequences of all mutated channel constructs were verified in full.
Heterologous expression of HCN channel constructs. HEK293 cells were cultured using standard procedures and transiently transfected with HCN channel constructs, together with a green fluorescent protein plasmid (pGreenLantern; Invitrogen, San Diego, CA), using either CaPO 4 precipitation or Lipofectamine 2000 reagent (Invitrogen). Recordings were obtained 2-4 d after transfection.
Electrophysiology. Whole-cell recordings were obtained at room temperature using 3-5 M⍀ patch pipettes and an Axopatch 200B amplifier in a bath solution composed of the following (in mM): 140 NaCl, 3 KCl, 2 MgCl 2 , 2 CaCl 2 , 10 HEPES, and 10 glucose, pH 7.3, that was perfused continuously (ϳ2 ml/min); the bath solution for slice recordings included tetrodotoxin (0.75 M) and was buffered to pH 6.5 to block pHand anesthetic-sensitive background K ϩ currents (Sirois et al., 2002) ; for recording HCN currents in HEK293 cells, the KCl concentration was raised to 25 mM (substituted equimolar for NaCl). Isoproterenol and 3-isobutyl-1-methylxanthine (IBMX) were obtained from Sigma (St. Louis, MO) and added to the bath at 1 and 100 M, respectively. Internal solution contained the following (in mM): 120 KCH 3 SO 3 , 4 NaCl, 1 MgCl 2 , 0.5 CaCl 2 , 10 HEPES, 10 EGTA, 3 Mg-ATP, and 0.3 GTP-Tris, pH 7.2; when noted, pipette solution was supplemented with cAMP (0.01-1.0 mM). Bath solutions containing anesthetics were equilibrated by bubbling with a room air gas mixture (21% O 2 /balance N 2 ) directed through calibrated vaporizers (Ohmeda, Liberty Corner, NJ); anesthetic concentrations were determined by gas chromatography of perfusate samples.
Data acquisition and analysis. Voltage-clamp commands were applied, and currents were recorded and analyzed using pClamp software and a Digidata 1322A digitizer (Axon Instruments, Union City, CA). Cells were held at Ϫ40 to Ϫ50 mV and subjected to a two-pulse protocol, with incrementing hyperpolarizing steps to generate time-dependent hyperpolarization-activated currents (I h , HCN), followed immediately by a step to fixed potential for measurement of tail currents. For I-V curves, current amplitudes during conditioning voltage steps were determined as the difference in current at the end of the voltage step from that measured at the beginning of the step, immediately after the capacitive transient (i.e., time-dependent current); no additional leak subtraction was applied for analysis. The amplitude of time-dependent current at the end of 2-6 s hyperpolarizing voltage steps (to Ϫ120 or Ϫ130 mV) was taken as maximal available current. Time constants () were obtained from biexponential fits to current activated during the hyperpolarizing steps. Absolute tail current amplitudes were measured, normalized between the maximum and minimum values, and fitted with Boltzmann curves for derivation of activation parameters (V 1/2 and k). Control experiments using longer conditioning steps at intermediate voltages (8 -10 s) for the slower HCN2 channels yielded V 1/2 values that were virtually identical to those obtained with steps of 4 -6 s duration. All data are expressed as means Ϯ SEM; statistical tests included one-and twoway ANOVA, Student's t test, or linear regression, as indicated, with p Ͻ 0.05 as criteria for acceptance as statistically significant.
In situ hybridization. In situ hybridization was performed for detection of HCN channel mRNA. Transverse brain sections (fresh frozen, 10 m) were obtained from Sprague Dawley rats, thaw mounted onto charged slides, and fixed, dehydrated, and delipidated. Sections were hybridized to [
33 P]UTP-labeled cRNA probes transcribed from EcoRI-digested HCN1-and HCN2-pcDNA3 using T7 RNA polymerase (Promega, Madison, WI) in hybridization buffer (50 ϫ 10 6 cpm/ml) containing 50% formamide, 4ϫ SSC (1ϫ SSC: 150 mM NaCl, 15 mM sodium citrate, pH 7), 1ϫ Denhardt's solutions (0.02% each of Ficoll, polyvinylpyrrolidone, and bovine serum albumin), 10% dextran sulfate, 100 mM DTT, 250 g/ml yeast tRNA, and 0.5 mg/ml salmon testes DNA. After hybridization, sections were rinsed in SSC and treated with RNase A [0.1 mg/ml in 10 mM Tris, 500 mM NaCl, and 1 mM EDTA, pH 7, for 30 min at 37°C (Boehringer Mannheim, Mannheim, Germany)] and exposed to film (Hyperfilm ␤MAX; Amersham Biosciences, Arlington Heights, IL) for 4 d or to liquid emulsion (NTB-2; Eastman Kodak, Rochester, NY) for 3-5 weeks.
Results
Halothane inhibits native motoneuronal I h by shifting voltage dependence and decreasing peak current amplitude Although I h is best known for contributions to pacemaker activity, the current can also affect integrative properties in nonpacemaker cells (for review, see Pape, 1996) . In motoneurons, which are not themselves pacemakers, I h is a prominent compo-nent of subthreshold current (Rekling et al., 2000) . As shown for a representative cell in Figure 1 , the inhalational anesthetic halothane caused a robust inhibition of motoneuronal I h , an effect that was manifest in at least two ways: analysis of tail currents at Ϫ90 mV after hyperpolarizing voltage steps to different membrane potentials revealed a halothane-induced leftward shift in the voltage range of activation ( Fig. 1 A, B, left) , whereas comparison of steady-state currents obtained at the end of the hyperpolarizing steps indicated that halothane decreased maximal I h amplitude ( Fig. 1 A, B, right) . On average, 0.8 mM halothane caused an approximate Ϫ10 mV shift in V 1/2 , the half-activation voltage, while also producing ϳ29% decrease in current amplitude measured at Ϫ130 mV. Although halothane appeared to slow I h activation kinetics at all potentials, there was no difference in activation kinetics when membrane potential was corrected for the hyperpolarizing shift in V 1/2 of activation (i.e., V m Ϫ V 1/2 ) (see supplemental data, available at www.jneurosci.org as supplemental material). Thus, halothane-induced inhibition of I h in motoneurons results from a shift in activation to more hyperpolarized potentials and a decrease in maximal current amplitude, with no change in the relationship between activation kinetics and activation voltage. It is important to point out that the combined effect of this inhibition is essentially a complete abolition of I h at all membrane potentials depolarized to Ϫ90 mV (e.g., see Fig. 1 B, right, filled squares).
Motoneurons express HCN1 and HCN2 subunits, which are differentially modulated by anesthetics The HCN family of ion channels represents the molecular substrate for neuronal I h , and in situ hybridization experiments indicate that motoneurons express two HCN subunits, HCN1 and HCN2 (Fig.  1C) , with an apparent predominance of the HCN1 subunit (Moosmang et al., 1999; Monteggia et al., 2000; Santoro et al., 2000) . These two HCN subunits produce homomeric channels that differ markedly in activation properties; HCN2 currents activate more slowly and at more hyperpolarized potentials than HCN1 currents Santoro and Tibbs, 1999; Kaupp and Seifert, 2001) .
We expressed these cloned HCN subunits as homomeric channels in HEK293 cells and found that they also differed in their modulation by halothane (Fig. 2) . Specifically, the two anesthetic effects on I h in motoneurons (hyperpolarizing shift in I h activation and decrease in maximal I h amplitude) segregated with the two individual subunits. Thus, halothane caused a hyperpolarizing shift in V 1/2 in cells expressing HCN1, with little effect on amplitude ( Fig. 2 A, B , top panels), whereas it decreased HCN2 current amplitude without substantially changing the voltage range of HCN2 activation (Fig. 2 A, B , middle panels). Note that the initial V 1/2 of HCN1 (Ϫ80.5 Ϯ 0.6 mV; n ϭ 50) was substantially more depolarized than that of HCN2 (Ϫ98.6 Ϯ 0.6 mV; n ϭ 57), as expected for these cloned channels Santoro and Tibbs, 1999; Kaupp and Seifert, 2001) .
It is now clear that HCN subunits can form heteromeric channels Ulens and Tytgat, 2001; Much et al., 2003) . To test effects of halothane on heteromeric HCN channels, we linked HCN1 and HCN2 cDNAs in a concatemeric arrangement and expressed the linked construct in HEK293 cells; this HCN1-HCN2 heteromeric channel produced hyperpolarizationactivated currents with kinetic and voltage-dependent properties intermediate to those of the constituent HCN1 and HCN2 subunits, as reported previously Ulens and Tytgat, 2001) . Consistent with an independent contribution of each subunit to halothane inhibition of the heteromeric channel, the anesthetic modulated HCN1-HCN2 currents via mechanisms attributable to both HCN1 and HCN2, causing a shift in V 1/2 and a decrease in maximal current amplitude (Fig. 2 A, B , bottom panels). Indeed, results with heteromeric HCN1-HCN2 channels were most similar to those from motoneurons (compare Figs. 1 B, 2 B, bottom panels), because halothane induced an approximate Ϫ10 mV shift in V 1/2 (from Ϫ86.9 Ϯ 1.2 to Ϫ96.5 Ϯ 1.1 mV; n ϭ 12) and ϳ18% decrease in maximal HCN1-HCN2 current amplitude.
Halothane also modulated current kinetics in an HCN subunit-dependent manner. When corrected for shifts in V 1/2 , halothane caused a speeding of HCN1 and a slowing of HCN2 current activation (see supplemental data, available at www. Halothane causes a hyperpolarizing shift in I h activation and a decrease in maximal I h amplitude in motoneurons that express HCN1 and HCN2 subunits. A, Representative sample currents from motoneurons during hyperpolarizing steps (⌬-10 mV) from Ϫ50 to Ϫ140 mV (top), before and during exposure to halothane (0.8 mM). Tail currents were evoked at Ϫ90 mV after the hyperpolarizing step (bottom); traces near the half-activation potential (V 1/2 ) under control and halothane conditions are shaded. For presentation of motoneuronal data, leak currents were subtracted from sample records obtained during the initial hyperpolarizing voltage steps (top). B, Left, Activation curves for I h were determined from Boltzmann fits to normalized tail currents; averaged data (ϮSEM; inset) indicate that halothane induced an approximate Ϫ10 mV shift in V 1/2 of activation (from Ϫ90.9 Ϯ 2.0 to Ϫ100.7 Ϯ 2.4 mV; n ϭ 9; p Ͻ 0.0001). Right, Halothane decreased current amplitude measured at the end of hyperpolarizing steps; averaged data (ϮSEM; inset) show that halothane decreased motoneuronal I h at Ϫ130 mV by 28.8 Ϯ 3.8% (n ϭ 9; p Ͻ 0.001). C, In situ hybridization with [
33 P]-labeled cRNA probes revealed high levels of HCN1 and moderate levels of HCN2 subunit transcripts in motoneurons of the hypoglossal nucleus. Dark-field images of emulsion-dipped slides illustrate the localization of HCN1 and HCN2 mRNA in hypoglossal motoneurons. Scale bar, 50 m. Film autoradiographs (insets) depict representative brainstem sections. cc, Central canal.
jneurosci.org as supplemental material). It is important to note that, although activation kinetics were altered by halothane, changes in activation cannot account for inhibitory actions of the anesthetic on current amplitude or V 1/2 in HCN channels. The decrease in HCN2 current amplitude by halothane was obtained at the end of 4 s pulses to Ϫ120 mV, at a time point that represents approximately six times the activation at that potential in halothane (635 Ϯ 150 ms; n ϭ 7). Moreover, the inhibition determined by using 6 s pulses (28.7 Ϯ 1.1% inhibition; n ϭ 3), after ϳ9 , was essentially identical to that obtained with our standard 4 s pulses (33.2 Ϯ 3.3% inhibition; n ϭ 17). Measured values of V 1/2 for I h can be exaggerated in the hyperpolarized direction under conditions when equilibration is incomplete at intermediate voltages (Kaupp and Seifert, 2001) , and this can be particularly problematic if current activation is slow (as it is with HCN2 and especially with HCN2 in halothane). However, our values for V 1/2 with HCN2 were stable with longer conditioning pulse durations (8 -10 s; data not shown). Moreover, we find that halothane had little effect on V 1/2 of the HCN2 channels despite slowing current activation, whereas the anesthetic induced a substantial hyperpolarizing shift in V 1/2 of the HCN1 channels in which it accelerated current activation. Therefore, effects of halothane on V 1/2 of HCN1 and HCN2 are opposite of that expected if they had resulted from altered activation kinetics.
In contrast to its effects on activation kinetics in HCN1 and HCN2 homomeric channels, halothane did not change activation kinetics in HCN1-HCN2 heteromeric channels (see supplemental data, available at www.jneurosci.org as supplemental material). Thus, effects of halothane on HCN1-HCN2 channels were intermediate between those on HCN1 and HCN2 homomeric channels and again resembled more closely the characteristics of inhibition in motoneurons in which halothane did not change current activation kinetics. Together, these data indicate that both HCN1 and HCN2 channel subunits contribute to the motoneuronal I h current and its inhibition by halothane.
HCN channels are modulated by inhalation anesthetics at clinically relevant concentrations
Distinct anesthetic actions occur over a submillimolar concentration range, with an EC 50 for immobilization of ϳ0.3 mM and progressive EEG depression up to 1 mM (Franks and Lieb, 1994; Eckenhoff and Johansson, 1999) . Effects of halothane on HCN channels were dose dependent within this clinically relevant concentration range (Fig. 2C,D) . Significant shifts in V 1/2 were evident at 0.3 mM halothane (HCN1, Ϫ9.0 Ϯ 0.7 mV, n ϭ 26; HCN2, Ϫ3.6 Ϯ 0.6 mV, n ϭ 31; HCN1-HCN2, Ϫ8.2 Ϯ 0.7 mV, n ϭ 15), with near-maximal shifts in gating obtained at 0.5 mM halothane for HCN1 (approximately Ϫ13 mV) and HCN1-HCN2 (approximately Ϫ10 mV). Inhibition of current amplitude was significant at halothane concentrations of 0.5 mM for both HCN2 (ϳ27% inhibition) and HCN1-HCN2 (ϳ14% inhibition).
The halogenated ether anesthetic isoflurane had effects essentially identical to those of halothane (data not shown): isoflurane (0.9 mM) caused a hyperpolarizing shift in V 1/2 of HCN1 and HCN1-HCN2 channels (Ϫ10.1 Ϯ 0.9 mV, n ϭ 4; Ϫ10.6 Ϯ 1.8 mV, n ϭ 6), with little effect on HCN2 (Ϫ3.7 Ϯ 1.5 mV; n ϭ 6), Figure 2 . HCN1 and HCN2 subunits are associated, respectively, with a halothane-induced hyperpolarizing shift in V 1/2 or a decrease in maximal current amplitude. A, Sample currents from HEK293 cells expressing HCN1, HCN2, or a linked heteromeric HCN1-HCN2 construct evoked by hyperpolarizing voltage steps (⌬-10 mV) from Ϫ40 to Ϫ120 mV before, during, and after exposure to a maximal concentration of halothane (0.8 mM); voltage steps were of different duration for the three constructs (2-4 s) and followed by a step to Ϫ90 mV for tail current analysis. Shaded traces are near the control V 1/2 and at the same potential in halothane. B, Activation curves were determined from tail currents (left) and steady-state I-V curves from currents at the end of the voltage steps (right) under control conditions (open squares), during exposure to halothane (filled squares), and after recovery (open triangles) for HCN1, HCN2, or a linked HCN1-HCN2 construct. C, Concentration-response curves for the halothane-induced shift in V 1/2 ; averaged ⌬V 1/2 values (n Ͼ 8 per group) were fitted with logistic curves using maximal ⌬V 1/2 of Ϫ16, Ϫ4, and Ϫ10 mV and EC 50 values of 0.33, 0.21, and 0.21 mM for HCN1 (triangles), HCN2 (diamonds), and HCN1-HCN2 (squares). Data analysis by two-way ANOVA revealed significant main effects for HCN constructs (F (2,146) ϭ 53.5; p Ͻ 0.0001) and halothane concentrations (F (2,146) ϭ 5.7; p Ͻ 0.005). D, Concentration-response curves for the halothane-induced inhibition of steadystate HCN current; averaged values (n Ͼ 8 per group) were fitted with logistic curves with maximal inhibition of 7, 41, and 21% and EC 50 values of 0.40, 0.40, and 0.39 mM for HCN1 (triangles), HCN2 (diamonds), and HCN1-HCN2 (squares). Data analysis by two-way ANOVA revealed significant main effects for HCN constructs (F (2,142) ϭ 23.3; p Ͻ 0.0001) and halothane concentrations (F (2,142) ϭ 11.1; p Ͻ 0.0001).
whereas it inhibited maximal current amplitude in HCN2 and HCN1-HCN2 channels (19.6 Ϯ 4% inhibition, n ϭ 6; 20.6 Ϯ 7.2% inhibition, n ϭ 6) but did not decrease HCN1 current amplitude (Ϫ3.7 Ϯ 4.1% inhibition; n ϭ 4).
In chimeric channels, distinct channel domains are necessary for HCN gating and amplitude modulation by halothane Anesthetic actions on current amplitude and gating segregated with individual HCN subunits, suggesting that separate structural determinants might account for these distinct anesthetic effects. We therefore tested effects of halothane on chimeric constructs in which the N terminus, transmembrane segments, or C terminus were exchanged between HCN1 and HCN2 subunits [denoted by HCN: N terminus, transmembrane segments, C terminus (as by Wang et al., 2001) ]. As illustrated in Figure 3 , A and B (also see supplemental data, available at www.jneurosci.org as supplemental material), halothane caused a large hyperpolarizing shift in V 1/2 only in those chimeric channels that contained the C terminus of HCN1, whereas inhibition of current amplitude by halothane tracked with the transmembrane segments of HCN2. In two constructs containing the transmembrane segments of HCN2 and the C terminus of HCN1 (HCN221 and HCN121), halothane caused both a shift in V 1/2 and a decrease in current amplitude. Conversely, halothane had little effect on gating or current amplitude in HCN212 and HCN112 chimeric channels that contained the C terminus of HCN2 and the transmembrane segments of HCN1. Halothane was not completely without effect on these latter two chimeras, because it still caused a speeding of current activation (Fig. 3A, sample traces) . In fact, the enhancement of activation kinetics typically associated with anesthetic modulation of HCN1 was retained in chimeras containing HCN1 transmembrane segments, whereas the slowed activation typical of HCN2 was observed in chimeras containing HCN2 transmembrane segments (data not shown).
Additional chimeric constructs were used to localize more precisely the effects of halothane on gating and current amplitude within the C terminus and the transmembrane segments, respectively. The C terminus was divided into three regions (denoted X, B, and L): an extreme C terminal region, the CNBD, and a proximal C-linker region (i.e., the sequence between the final transmembrane spanning domain and the CNBD). Swapping these individual domains in chimeric channels revealed that halothane-induced actions on V 1/2 of activation depend on both the CNBD and the C linker of the subunits, with the C-linker domain appearing most critical (Fig. 3C,D) . Thus, although incorporating either the HCN1 linker domain or CNBD into an HCN2 subunit (HCN2-1L, HCN2-1B) enhanced the halothane- Figure 3 . Anesthetic modulation of current amplitude and voltage dependence track with different channel domains in HCN channel chimeras. Currents were evoked from HEK293 cells expressing HCN1, HCN2, or the indicated chimeric HCN channel constructs (n Ͼ 6 per group) by using hyperpolarizing voltage steps (⌬-10 mV) from Ϫ40 to Ϫ120 mV, before and during exposure to a maximal concentration of halothane (0.8 mM); voltage steps were followed by a test pulse to Ϫ90 mV for tail current analysis. A, Sample records from chimeras that swapped the N-terminal, transmembrane, or C-terminal regions between HCN1 and HCN2 subunits. B, Averaged (ϮSEM) halothane-induced shift in V 1/2 (left) and current inhibition (right) were determined from cells expressing HCN chimeric channels. C, Sample currents from C-terminal chimeras of HCN subunits in which the C-linker (L), CNBD (B), or extreme C terminus (X) were swapped between HCN1 and HCN2. D, Averaged (ϮSEM) halothane-induced shift in V 1/2 (left) and current inhibition (right) in C-terminal chimeras of HCN channels. E, Sample currents from chimeras of HCN subunits in which the core channel domains (S5-S6) were exchanged between HCN1 and HCN2. F, Averaged (ϮSEM) halothaneinducedshiftinV 1/2 (left)andcurrentinhibition(right)incorechannelchimerasofHCNsubunits.Shadedtracesindicatestepstoavoltage near V 1/2 under control conditions and to the same potential in halothane. Calibrations: 500 ms, 1 nA, except when noted.
induced hyperpolarizing shift in V 1/2 , the anesthetic effect on gating was fully lost only when the linker domain of HCN2 was included in HCN1 (HCN1-2L). As expected based on chimeras described above, amplitude inhibition by halothane was prominent in all constructs that included the transmembrane segments of HCN2 but was absent in all constructs containing an HCN1 transmembrane region (see Fig.  3D, right) .
We produced a final pair of chimeras that swapped the core channel domains of the transmembrane segments (i.e., the fifth and sixth transmembrane domains and the intervening pore helix, S5-S6). As shown in Figure 3 , E and F, current amplitude was not inhibited by halothane in the HCN2 channel construct that included pore-forming regions from HCN1 [i.e., HCN1-2(S5-S6), also HCN1-2P], whereas incorporating the corresponding channel core of HCN2 into HCN1 [i.e., HCN2-1(S5-S6), also HCN2-1P] conferred amplitude modulation by halothane, together with a shift in gating. It is worth noting that effects of halothane on current kinetics also localized to this S5-S6 core channel region; as with HCN2, halothane slowed current activation in HCN1-2(S5-S6) constructs, and, as with HCN1, halothane sped activation in the HCN2-1(S5-S6) construct (data not shown).
In summary, data from these experiments with chimeric constructs indicate that halothane inhibits channels containing S5-S6 domains of HCN2 by decreasing current amplitude and activation kinetics; conversely, halothane causes a shift in V 1/2 of activation in channels containing HCN1 C-terminal regions, especially the C-linker domain. These results are consistent with an interpretation that independent inhibitory actions of halothane (on amplitude and V 1/2 ) are mediated at distinct sites within the channel. However, because different domains from HCN1 and HCN2 subunits can allosterically modulate basal channel function in distinct ways (Wainger et al., 2001; Wang et al., 2001; Zagotta et al., 2003; Craven and Zagotta, 2004) , it is also possible that the form of anesthetic inhibition is actually determined by the basal properties of the channel that those domains regulate (see below). We explored this possibility by taking advantage of the ability of cAMP to abrogate differences in basal inhibition between HCN1 and HCN2 channels. (Wainger et al., 2001) ], but allosteric inhibition is more prominent in channels containing an HCN2 C terminus than in those with an HCN1 C terminus. The different inhibitory effects of the respective proximal C-terminal domains are thus proposed to account for the more hyperpolarized initial V 1/2 in HCN2 than in HCN1 channels and for the larger depolarizing shift in V 1/2 by cAMP in HCN2 channels (i.e., stronger relief by cAMP of the basal inhibition) (Wainger et al., 2001; Wang et al., 2001) . Strikingly, our chimera experiments map differences in halothane-induced modulation of gating of HCN1 and HCN2 to the same proximal C-terminal channel domains responsible for differences in effects of cAMP on these channels (Wainger et al., 2001; Wang et al., 2001 ). In the case of halothane, however, the shift in V 1/2 is in the opposite direction as that induced by cAMP and with an opposite subunit sensitivity (i.e., HCN1 is more sensitive than HCN2). To confirm this, we recorded HCN channels and chimeric constructs in the presence of saturating concentrations of cAMP in the pipette (50 M). As shown in Figure 4 A and in agreement with previous work , we found that cAMP caused a depolarizing shift in V 1/2 in chimeric channels that, although influenced by transmembrane segments, was primarily determined by C-terminal domains. Notably, the pattern of modulation by cAMP of these chimeric HCN channels is C, The hyperpolarizing shift in V 1/2 induced by halothane (left) and the depolarizing shift in V 1/2 induced by cAMP (right) were negatively correlated across all HCN constructs, with the best fit line yielding a slope factor approaching Ϫ1 (m ϭ Ϫ0.9; R 2 ϭ 0.71; F (1,15) ϭ 35.9; p Ͻ 0.0001). In B and C, data are from HCN1 (triangles), HCN2 (diamonds), HCN1-HCN2 (squares), and chimeric HCN channels (filled circles). Each point represents averaged data (ϮSEM) from one of the HCN channel constructs (n Ͼ 6 per group); values from each HCN channel construct are provided in the supplemental table (available at www.jneurosci.org as supplemental material).
opposite that described above for halothane (compare Fig. 4A with Fig. 3) .
In light of the allosteric inhibition model for cAMP modulation, we examined the correlation between initial V 1/2 of the HCN channel constructs and either the hyperpolarizing shift caused by halothane (Fig. 4 B, left) or the depolarizing shift in V 1/2 caused by cAMP (Fig. 4 B, right) : HCN constructs with more hyperpolarized initial V 1/2 show relatively smaller hyperpolarizing shifts by halothane and larger depolarizing shifts by cAMP, and, conversely, constructs with more depolarized initial V 1/2 have larger shifts by halothane and smaller shifts by cAMP. Indeed, the negative correlation between the depolarizing shift in V 1/2 caused by cAMP and the hyperpolarizing shift in V 1/2 induced by halothane was especially tight across all of these constructs (Fig. 4C) , with a slope that approaches Ϫ1 (Ϫ0.9). Thus, mutations that change the initial V 1/2 of the HCN channels have nearly equal but opposite effects on the modulation by cAMP and halothane. Interpreted in terms of the model described above for differences in cAMP modulation of HCN channels, this suggests that subunit-specific differences in effects of halothane on gating might reflect the degree of tonic allosteric inhibition associated with each chimeric subunit; that is, channels with less basal inhibition imposed by the C-terminal domains are more sensitive to inhibitory gating effects of halothane.
To test directly the hypothesis that differences in effects of halothane reflect the degree of basal inhibition associated with each subunit, we examined halothane modulation of HCN channel constructs after relieving that basal inhibition with cAMP. Sample currents from homomeric HCN1 and HCN2 and heteromeric HCN1-HCN2 channels recorded with cAMP demonstrate that halothane had little effect on maximal current amplitude in any construct (Fig. 5A) . Moreover, as presented in Figure 5B , the initial V 1/2 was relatively depolarized and essentially identical for all these constructs in the presence of cAMP (approximately Ϫ75 mV), and, under these conditions of reduced basal inhibition, the hyperpolarizing shift induced by halothane was also similar.
The most dramatic differences in halothane modulation attributable to cAMP were observed with HCN2 channel currents, for which halothane induced a substantial shift in V 1/2 (approximately Ϫ10 mV) and inhibited current amplitude by Ͻ10% in the presence of cAMP, actions that were clearly different from the more modest shift and much greater amplitude inhibition (ϳ40%) induced by halothane when cAMP was not included in the pipette. We obtained similar results when cAMP levels were increased by forskolin (10 M, bath applied); halothane decreased HCN2 amplitude by Ͻ10% (8.9 Ϯ 5.1% inhibition; n ϭ 11) while inducing an approximate Ϫ10 mV shift in V 1/2 (Ϫ10.1 Ϯ 2.7 mV; n ϭ 11). The relationship between basal inhibition (i.e., the initial V 1/2 before a halothane challenge) and either the halothane-induced shift in V 1/2 (top) or amplitude inhibition (bottom) is plotted for HCN1, HCN2, and HCN1-HCN2, with and without cAMP, in Figure 5C . Overall, cAMP had little effect on halothane inhibition of HCN1 currents (triangles), consistent with its relatively minor modulation of the basal inhibition of those channels. Conversely, cAMP clearly relieved basal inhibition (i.e., caused a depolarizing shift in initial V 1/2 ) in HCN2 channels (diamonds), and to a lesser extent in HCN1-HCN2 heteromeric channels (squares), and correspondingly enhanced the gating effects of halothane while decreasing its inhibition of current amplitude.
We also determined the effect of cAMP on halothane-induced inhibition in all chimeric HCN channels (Fig. 5D-G) . When recorded with cAMP in the pipette, the initial V 1/2 was relatively Figure 5 . Relief of basal inhibition by cAMP changes the characteristics of halothane inhibition in channels that include an HCN2 C terminus. HCN channel currents were recorded in HEK293 cells with pipettes that contained saturating concentrations of cAMP (50 M). A, Sample currents evoked from cells expressing HCN1, HCN2, or heteromeric HCN1-HCN2 channels (n Ͼ 6 per group), before and during exposure to a maximal concentration of halothane (0.8 mM); shaded traces are near the control V 1/2 and at the same potential in halothane. Note that halothane had little effect on current amplitude from cAMP-loaded cells expressing HCN channels. B, In the presence of cAMP, averaged activation curves (ϮSEM) were determined from tail currents under control conditions and during exposure to halothane for HCN1, HCN2, and HCN1-HCN2. C, Relationship between initial V 1/2 , a measure of basal inhibition, and either the hyperpolarizing shift in V 1/2 (top) or the amplitude inhibition (bottom) induced by halothane in cells expressing HCN1, HCN2, and HCN1-HCN2 under control conditions or in the presence of cAMP. D, Averaged shift in V 1/2 (ϮSEM) for all chimeric constructs determined in the absence and presence of cAMP. E, Relationship between initial V 1/2 and the hyperpolarizing shift in V 1/2 induced by halothane for all HCN channel constructs recorded in the absence and presence of cAMP; the overlaid regression line is from Figure 4 B. In the presence of cAMP, halothane caused a voltage-dependent shift in gating in all HCN constructs. F, Averaged amplitude inhibition (ϮSEM) for HCN channel constructs determined in the absence and presence of cAMP. G, Relationship between initial V 1/2 and current inhibition by halothane for all HCN channel constructs recorded in the absence and presence of cAMP; the overlaid line is the fit obtained to data from HCN1, HCN2, and HCN1-HCN2 channels. In the presence of cAMP, amplitude inhibition was lost from all HCN constructs except those indicated, which included an HCN1 C terminus together with an HCN2 channel core. Data points represent averaged data (ϮSEM; n Ͼ 6 per construct). In E and G, data are from HCN1 (triangles), HCN2 (diamonds), HCN1-HCN2 (squares), and chimeric HCN channels (circles) in the absence (open symbols) and presence (filled symbols) of cAMP.
depolarized for all constructs, and halothane caused a large hyperpolarizing shift in V 1/2 in all mutant channels. This included those chimeras containing a C-linker domain from HCN2 in which halothane induced only a small shift in V 1/2 under control conditions but an augmented shift when cAMP was included in the pipette (e.g., see Fig. 5D , HCN212, HCN1-2L, or HCN2-1P). As shown in Figure 5E , the relationship between initial V 1/2 and the anesthetic-induced shift in V 1/2 for all chimeric channels conformed to that described above for wild-type channels. Also, for chimeric channels that included an HCN2 C-linker domain, if halothane had a strong effect on current amplitude in control conditions, the amplitude modulation was lost in the presence of cAMP (e.g., see Fig. 5F , HCN122, HCN2-1B or HCN2-1X). Note, however, that amplitude inhibition was retained in chimeras in which an HCN2 core was combined with an HCN1 C linker (constructs indicated in Fig. 5G ). This may reflect differences in conformational coupling between modules from different subunits in these chimeric channels (Craven and Zagotta, 2004) because the HCN1 C linker is less effective in conveying cAMP modulation to HCN2 core domains ).
So, cAMP had little effect on the form of anesthetic modulation in weakly cAMP-sensitive HCN channels (i.e., HCN1 and chimeras containing an HCN1 proximal C terminus). In contrast, for the most strongly cAMP-sensitive HCN channels (i.e., HCN2 or chimeras containing an HCN2 core together with the proximal C terminus of HCN2), cAMP reduced basal inhibition and converted halothane inhibition from primarily a decrease in maximal current amplitude to a more HCN1-like pattern (i.e., a hyperpolarizing shift in V 1/2 with little amplitude modulation).
Gating and amplitude inhibition by halothane are preserved in C-terminal deletion mutants of HCN channels
The data indicate that the form of channel inhibition by halothane (gating shift or amplitude inhibition) depends to a large extent on the C-terminal domains of the channels, particularly the C linker, and the extent to which those domains modulate basal channel activity. We wondered whether the primary site of halothane action was actually contained in those C-terminal regions, or whether those domains provide an allosteric modulation of halothane effects that are mediated elsewhere in the channel. To test this, we examined inhibition by halothane of HCN channel mutants in which the C terminus was deleted beyond the C linker in both HCN1 and HCN2 (i.e., HCN1⌬CNBD and HCN2⌬CNBD) or removed completely by truncation immediately after the final transmembrane segment of HCN1 (HCN1⌬Cterm); we could not test the corresponding complete C-terminal deletion in HCN2 because, as reported previously (Wainger et al., 2001) , we found that HCN2⌬Cterm did not generate currents. As shown in the sample records and activation plots of Figure 6 , halothane caused a strong shift in V 1/2 together with a robust inhibition of maximal current amplitude in all deletion mutants. These data indicate that neither inhibitory action of halothane requires a direct interaction of the anesthetic with the C-terminal domains, and that inhibition by halothane is essentially identical in HCN1 and HCN2 subunits in the absence of their respective C termini. Together with previous results from chimeric channels, these data also imply that proximal C-terminal regions modulate, rather than mediate, HCN channel inhibition by halothane.
Inhibition by halothane also depends on prevailing basal inhibition in neurons Our recordings from cloned channels indicate that halothane caused primarily inhibition of current amplitude in homomeric channels containing HCN2 subunits, with little effect on gating; this form of inhibition could be primarily attributed to basal inhibition of channel activity imposed by the C-terminal domains of those HCN2 subunits. In channels with less basal inhibition, such as those that include HCN1 subunits (e.g., HCN1-HCN2 or HCN1 channels), or when basal inhibition by HCN2 subunits was reduced (e.g., in the presence of cAMP), the effects of halothane were characterized more by gating shifts than by amplitude modulation. We tested whether this dependence on basal inhibition, and its modulation by cAMP, was also apparent in native neuronal I h (Fig. 7) . For this, we chose to study neurons with a relatively high ratio of HCN2 to HCN1 expression, as shown by in situ hybridization for neurons of the deep cerebellar nuclei (DCN) (Fig. 7A) (Monteggia et al., 2000; Santoro et al., 2000) .
As illustrated for a DCN neuron recorded without cAMP in the pipette (Fig. 7B) , the initial V 1/2 of I h activation was relatively hyperpolarized (approximately Ϫ93 mV), indicative of a high degree of basal inhibition, like HCN2. Accordingly, the effect of halothane on I h in this cell was also similar to that seen with HCN2 in the absence of cAMP: halothane had little effect on V 1/2 but strongly decreased maximal current amplitude. In a DCN neuron recorded with cAMP in the pipette (Fig. 7C) , basal inhibition was reduced (initial V 1/2 of approximately Ϫ81 mV), and, in this case, halothane caused a strong hyperpolarizing shift in Figure 6 . In C-terminally deleted HCN channels, halothane inhibition includes both a decrease in current amplitude and a shift in voltage dependence. Currents were recorded from HCN channel constructs with C-terminal truncations at the end of the sixth transmembrane segment (HCN1⌬Cterm) or after the C linker (HCN1⌬CNBD and HCN2⌬CNBD) . A, Sample currents from the indicated constructs are shown before and during exposure to halothane; the anesthetic caused a strong inhibition of maximal current. Shaded traces are near the control V 1/2 and at the same potential in halothane. B, Activation curves were determined from tail currents (left) and steady-state I-V curves from currents at the end of the voltage steps (right) in C-terminally deleted channels under control conditions (open squares) and during exposure to halothane (filled squares). Halothane induced a shift in V 1/2 of activation and a decrease in maximal current amplitude.
V 1/2 with little effect on current amplitude, similar to its actions on HCN2 channels in the presence of cAMP.
In recordings from a population of predominantly HCN2-expressing DCN and thalamocortical neurons (Monteggia et al., 2000; Santoro et al., 2000) , with and without cAMP in the pipette, we obtained a distribution of initial V 1/2 values reflecting variable degrees of initial basal inhibition. As shown by the correlations in Figure 8 A, the level of basal inhibition was highly predictive for the magnitude of halothane effects on gating and current amplitude. We compared neurons recorded without cAMP in the pipette that displayed high basal inhibition (initial V 1/2 of less than Ϫ95 mV) with those recorded with cAMP that showed low basal inhibition (initial V 1/2 of more than Ϫ85 mV). Low basal inhibition was associated with an enhanced halothane-induced shift in V 1/2 and a decreased current inhibition (Fig. 8 B) . Likewise, we used the ␤-adrenoceptor agonist isoproterenol to stimulate endogenous adenylyl cyclase activity in thalamocortical neurons with similar results; receptor-mediated increases in cAMP shifted initial V 1/2 (by 6.7 Ϯ 0.3 mV; n ϭ 5) and, as shown in Figure 8C , coordinately increased the halothane-induced hyperpolarizing shift in V 1/2 while decreasing amplitude inhibition. Thus, as observed with cloned channels containing HCN2 subunits, elevated cAMP lowers basal inhibition of neuronal channels such that inhibition of I h results primarily from a change in V 1/2 rather than a decreased current amplitude (i.e., anesthetic inhibition becomes more HCN1-like).
Discussion
Inhibition of native neuronal I h by inhaled anesthetics is manifest in two effects, a hyperpolarizing shift in voltage dependence of activation and a decrease in maximal available current, that effectively block the current over the typical subthreshold voltage range. We show that these effects represent actions on distinct HCN channel subunits, HCN1 and HCN2, respectively, and both actions are recapitulated in HCN1-HCN2 heteromeric channels. Inhibition of HCN channels occurs over a clinically relevant concentration range, with near-maximal effects (approximately Ϫ10 mV shift in V 1/2 of HCN1 or ϳ30% decrease in HCN2 current amplitude) at halothane concentrations Յ0.5 mM. Our experiments with chimeric and deletion constructs of HCN1 and HCN2 indicate that inhibition by halothane of core channel activity in HCN1 and HCN2 is actually similar, but that allosteric modulation by proximal C-terminal domains dictates the form of inhibition observed. For cloned HCN channels and I h in different neuron groups, we observed strong correlations between strength of basal inhibition, defined by initial V 1/2 of current activation, and either amplitude inhibition or gating shifts induced by halothane. Together, these data demonstrate that halothane modulation of native neuronal I h is represented by more prominent gating effects in channels that include HCN1 subunits and relatively greater amplitude inhibition in channels that include HCN2 subunits; by interacting with C-terminal domains, cAMP pushes HCN2 channels into a state of lower basal inhibition (i.e., more depolarized V 1/2 ) in which actions of halothane are characterized by larger shifts in V 1/2 and smaller decreases in maximal available current (i.e., more HCN1-like). The strong inhibition of HCN channels by halothane at concentrations obtained during general anesthesia (Franks and Lieb, 1994; Eckenhoff and Johansson, 1999) , together with the recognized role of I h in CNS functions that are affected by general anesthesia (e.g., thalamocortical rhythms) (Steriade et al., 1993; McCormick and Bal, 1997; Alkire et al., 2000; Antkowiak, 2002; Harrison, 2002; Campagna et al., 2003) , suggest that I h modulation may contribute to clinical actions of these important drugs.
Allosteric modulation of halothane-mediated HCN channel inhibition by C-terminal domains and cAMP
In chimeric channels, the two forms of I h inhibition associated with HCN1 or HCN2 tracked remarkably well with two distinct domains of these subunits; the proximal C-terminal region of HCN1 was necessary for halothane-induced gating shifts, whereas amplitude inhibition occurred only in chimeras that included core channel domains of HCN2. However, this seemingly strict structural demarcation was violated in the presence of cAMP, a condition that permitted halothane-induced gating shifts with little amplitude modulation in wild-type HCN2 channels or in chimeric channels that included C-terminal domains of HCN2. These results with cAMP implied that the different forms of halothane-induced channel inhibition were not attributable solely to the presence or absence of particular channel domains, a conclusion that was borne out by the demonstration that both forms of inhibition were induced simultaneously by halothane in C-terminal deletion mutants of either HCN1 or HCN2. Moreover, because inhibition by halothane of C-terminally deleted HCN1 and HCN2 channels was indistinguishable, distinct properties attributable to the cognate C termini must account for different modes of halothane-induced inhibition of intact HCN1 and HCN2 channels. What are the known and distinct modulatory characteristics of the C termini of HCN1 and HCN2 channels, and how might those influence the predominant mode of inhibition by halothane? Previous mutagenesis studies demonstrated that the C terminus of HCN2 imparts substantially more basal inhibition to its core channel domains than does the C terminus of HCN1, accounting for its more hyperpolarized initial V 1/2 (Wainger et al., 2001; Wang et al., 2001) ; binding of cAMP to the C terminus acts to relieve basal inhibition, producing a more prominent depolarizing shift in V 1/2 of HCN2 channels. Based on a simplified model of HCN channel gating, adapted from Shin et al. (2004) , we suggest that differences in C-terminally mediated basal inhibition can lead primarily to a shift in V 1/2 or amplitude inhibition despite a common underlying inhibitory mechanism, i.e., stabilization of channel closed state.
This concept is illustrated in Figure 9 , in which currents were simulated using a three-state model: a resting closed state (C R ) is separated from an activated closed state (C A ) by a voltagedependent gating transition with equilibrium constant K G ( V), and a second transition from C A to the conducting open state (O) is defined by a voltage-independent equilibrium constant (K O ). For this simulation, we used an identical K G ( V) for both HCN1 and HCN2, and we assigned 100-fold differences in the magnitude of K O to account for differences in C-terminally mediated basal inhibition in the subunits. With these parameters, the initial V 1/2 is more hyperpolarized in the model with 100-fold smaller K O (by approximately Ϫ21 mV), similar to differences observed between HCN1 and HCN2 channels. Under these different initial conditions, simulating channel modulation by halothane by applying identical fivefold decreases in K O to both models leads to apparently different forms of inhibition: with the higher initial K O , inhibition predominantly appears as a hyperpolarizing shift in V 1/2 (like HCN1), whereas with the lower initial K O , inhibition is primarily manifest as a decrease in maximal current amplitude (like HCN2). With an intermediate initial K O , the initial V 1/2 is also intermediate and the same fivefold decrease yields both forms of inhibition (like HCN1-HCN2). To account for the ability of cAMP to change halothane-induced modulation of HCN2 Simulated currents show either a shift in voltage dependence from a relatively depolarized initial V 1/2 , with little decrease in maximal current amplitude reminiscent of halothane effects on HCN1 (left), or a decrease in current magnitude, with minimal effect on a relatively hyperpolarized initial V 1/2 , similar to halothane inhibition of HCN2 (middle), when assessed using a 100-fold difference in the initial value of K O . With an intermediate initial value of K O (right), the initial V 1/2 is also intermediate, and the fivefold decrease in K O is manifest as both a shift in V 1/2 and a decrease in current amplitude, as observed with HCN1-HCN2 heteromeric channels. For the illustration, the voltage-dependent step (i.e., C R 3 C A ) was simulated assuming a steepness of e-fold per 6.5 mV and a midpoint of activation of Ϫ98 mV, as determined experimentally for HCN2; results are qualitatively identical using measured values from HCN1 (e-fold per 7 mV and a midpoint of activation of Ϫ80 mV). The simplified model [adapted from Shin et al. (2004) ] and the arbitrarily defined equilibrium constants are provided below the plots. Simulated currents were obtained with QuB freeware (http://www.qub.buffalo.edu/), and steady-state values were used to generate activation curves and determine relative current amplitudes.
and HCN1-HCN2 channels to a more HCN1-like pattern (i.e., gating shift with little amplitude inhibition), one need only propose that binding of cAMP decreases basal inhibition (increases initial K O ) to approximate that of HCN1, as has been demonstrated (Wainger et al., 2001; Wang et al., 2001) .
These arguments for distinct manifestations of channel inhibition are very similar to those proposed to account for different forms of activation induced by cAMP in two HCN channels (Shin et al., 2004) , although in that previous model, an inactivated state was introduced to account for the somewhat anomalous behavior of a sea urchin HCN channel. In addition, an analogous situation obtains in the related cyclic nucleotide-gated (CNG) channels (Fodor et al., 1997) . Inhibition of olfactory CNG channels by the local anesthetic tetracaine involved a shift in concentration dependence for cGMP, with little effect on current amplitude, whereas tetracaine strongly decreased maximal current amplitude in rod CNG channels; the relative expression of these two forms of inhibition was ascribed to differences in K O intrinsic to the two CNG channels (Fodor et al., 1997) .
We should note, however, some deviations in the data that suggest complexities in gating of chimeric channels that are not easily explained by our simple model, at least by its use of initial V 1/2 as a measure of basal inhibition (and K O ). For example, halothane had minimal effects on V 1/2 or current amplitude in chimeras combining core domains from HCN1 with proximal C termini from HCN2, whereas it produced strong inhibition of maximal current and a pronounced gating shift in constructs containing HCN2 core domains and HCN1 C-terminal regions, despite similar initial V 1/2 values (see supplemental data, available at www.jneurosci.org as supplemental material). Also, for those chimeras in which both inhibitory effects were evident (e.g., those that combine an HCN2 core with proximal C-terminal regions of HCN1), halothane continued to cause a strong decrease in current amplitude even when the initial V 1/2 was shifted to more depolarized potentials in the presence of cAMP (see Fig.  5G ). Of course, domain functions are unlikely to be completely interchangeable in chimeric channels, and these discrepancies may reflect altered conformational coupling from CNBD to C linker to the channel pore (Craven and Zagotta, 2004) . In this respect, the cAMP-bound HCN1 C terminus does not appear to modulate the HCN2 core to the same extent as does the natural cAMP-bound HCN2 C terminus (see also Wang et al., 2001 ). In addition, our model does not attempt to account for any differences in the voltage-dependent transition [K G ( V) ] that could result from domain mismatches in chimeric channels and, for example, in electrostatic interactions between C-linker and S4 -S5 linker domains that affect voltage dependence of HCN channels (Decher et al., 2004) . Nevertheless, the overall correlation between initial V 1/2 and either halothane-induced gating shifts or amplitude inhibition was upheld across the group of mutant HCN channels and, more importantly, was recapitulated in neurons expressing native I h channels. Moreover, the simple model illustrates a key point: a single mechanism can result in apparently distinct forms of inhibition of HCN channels.
Potential functional consequences of HCN channel modulation by anesthetics
We have shown that halothane inhibition of I h in neurons can include a shift in activation voltage, inhibition of current amplitude, or both, depending on HCN subunit composition and degree of tonic cAMP modulation. HCN channels represent a particularly provocative potential anesthetic target because subtle modulation of channel activity, as observed with physiological changes in cAMP levels, can contribute to substantially altered rhythmic activity patterns that accompany various behavioral states (e.g., the slow EEG rhythms of sleep, when I h is inhibited in thalamocortical neurons or the tachycardia of exercise, when sinoatrial nodal I f is enhanced) (DiFrancesco, 1993; Pape, 1996; Clapham, 1998; Lüthi and McCormick, 1998) . Moreover, although I h is best known for its contributions to cellular pacemaker behavior, the current is also present in many nonpacemaker neurons in which it can affect integrative properties in numerous ways: I h can stabilize resting membrane potential, mediate rebound depolarization and hyperpolarization, contribute to spike repolarization, decrease the amplitude and time course of spike afterhyperpolarization, and modify dendritic filtering of synaptic inputs (for review, see Pape, 1996) . It is likely, therefore, that modulation of I h by anesthetics in pacemaker and nonpacemaker cells can profoundly affect neuronal excitability, and we suggest that this modulation can contribute to clinical actions of volatile anesthetic agents. It will be important to determine, by using knock-out animals and/or computational models, how differential inhibition by anesthetics of either voltage dependence of activation or current amplitude, mediated by HCN1 or HCN2 subunits and modulated by cAMP, ultimately influences the actions of those anesthetics.
